Help Cure Muscular Dystrophy - Phase 2 is investigating protein interactions, focussing on those that play a role in neuromuscular diseases. The goal is to help researchers design molecules that inhibit or enhance binding of particular macromolecules, hopefully leading to better treatments for neuromuscular diseases, particularly muscular dystrophy.
The Decrypthon Program is a collaboration launched by AFM (French Muscular Dystrophy Association), CNRS (French National Center for Scientific Research) and IBM in May 2004. This partnership is a technical platform for grid computing which includes technical, financial, and human resources in which RENATER (French National Communication for Research and Network), Universities, and individual Internet users participate.
- Main article: Publications
Sacquin-Mora, Sophie; Carbone, Alessandra; Lavery, Richard (2008),
"Identification of Protein Interaction Partners and Protein–Protein Interaction Sites",
Journal of Molecular Biology 382 (5): 1276 - 1289, doi:10.1016/j.jmb.2008.08.002